about
Tumour biomarkers: homeostasis as a novel prognostic indicatorCancer biomarker discovery: the entropic hallmark.Multiscale integration of -omic, imaging, and clinical data in biomedical informatics.Establishing an in vivo model of canine prostate carcinoma using the new cell line CT1258.Bioengineered human arginase I with enhanced activity and stability controls hepatocellular and pancreatic carcinoma xenografts.Human tumor cell proliferation evaluated using manganese-enhanced MRI.Identifying in vivo DCE MRI markers associated with microvessel architecture and gleason grades of prostate cancerAtypical adenomatous hyperplasia (adenosis) of the prostate: a case report with review of the literature.Decreased P27 protein expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma.Androgen deprivation therapy in the treatment of locally advanced, nonmetastatic prostate cancer: practical experience and a review of the clinical trial evidence.The role of transperineal template biopsies of the prostate in the diagnosis of prostate cancer: a review.Betulinic Acid-Mediated Apoptosis in Human Prostate Cancer Cells Involves p53 and Nuclear Factor-Kappa B (NF-κB) Pathways.Clinical features and prognostic factors for patients with bone metastases from prostate cancer.Screening for Circulating Tumour Cells Allows Early Detection of Cancer and Monitoring of Treatment Effectiveness: An Observational StudyAnalysis of histological findings obtained combining US/mp-MRI fusion-guided biopsies with systematic US biopsies: mp-MRI role in prostate cancer detection and false negative.Pathological and oncological features of Korean prostate cancer patients eligible for active surveillance: analysis from the K-CaP registry.A cohort study of digoxin exposure and mortality in men with prostate cancer.Biopsy Core Features Are Poor Predictors of Adverse Pathology in Men with Grade Group 1 Prostate Cancer.Washout gradient in dynamic contrast-enhanced MRI is associated with tumor aggressiveness of prostate cancer.Hedgehog signaling protein expression and its association with prognostic parameters in prostate cancer: a retrospective study from the view point of new 2010 anatomic stage/prognostic groups.
P2860
Q28069898-A55AA5DB-9A67-480A-940C-F4A4C98D7BACQ30496149-01CD4781-21C6-4B99-8348-E599A33DE6E3Q30581136-548449DC-349B-4507-8DB7-D405C595BF62Q33360441-2953E384-0FD0-47F6-BE0E-713BFA768D1FQ35015474-2E0BF7A1-5356-45B3-8E81-66AF66B1CCC1Q35763597-9B12698F-98E6-41DE-9661-E1E8A8A6EC1DQ36404493-FA2A84C0-78E9-43D1-967A-5E16432CD0B9Q37242726-A69A20A3-CA45-434B-A35A-D66F42F3068CQ37425668-E27BE3BA-DAFB-4220-8256-216D21DDBCDDQ37735433-15DF878B-E2EE-46FD-9AF0-97807127873BQ38286399-2C41E66F-812F-4439-A526-785EC33E3EA9Q38716171-5E344FA5-ABB8-4E50-801C-A00FAD53BFE9Q42115590-376417D4-5EC5-4D90-9693-15E0BCAF2BAAQ47101682-DE45EAE8-D9B9-46A7-A925-7CD0346DDD4CQ47581196-E2CDE5FE-3FBE-4C57-BD73-9CDFA44DAA03Q47692316-3B2B764B-07CD-4309-8012-CD46759461D9Q47797325-E5C299E4-9D54-4A73-B008-F9938E6C2C3EQ50066944-52C3F49C-C5BB-4164-AA6D-11DD116175F7Q51353518-3E838026-098F-4EDD-B424-A59B8DEBDA65Q54365700-AA724D92-7B23-4F56-9061-CC321946E7E7
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Prognostic factors in prostate cancer.
@ast
Prognostic factors in prostate cancer.
@en
Prognostic factors in prostate cancer.
@nl
type
label
Prognostic factors in prostate cancer.
@ast
Prognostic factors in prostate cancer.
@en
Prognostic factors in prostate cancer.
@nl
prefLabel
Prognostic factors in prostate cancer.
@ast
Prognostic factors in prostate cancer.
@en
Prognostic factors in prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
Prognostic factors in prostate cancer.
@en
P2093
P2860
P2888
P356
10.1186/1746-1596-1-4
P577
2006-04-03T00:00:00Z
P5875
P6179
1007023252